WHO-GMP Certified Commercial Pack · Product Code: AKP-017
Itraconazole 100mg Capsules (Pellets)
Formulation Overview: Triazole antifungal capsule utilizing solid-dispersion sugar-sphere pellet technology to overcome poor aqueous solubility and maximize systemic absorption in dermatophytic and deep mycoses. Formulated with Itraconazole BP / IP 100 mg (Pelletized) (100 mg) in Supra-Bioavailable Pellet Capsules dosage form under Anti-Infectives & Antibiotics, manufactured to IP / BP / USP Compendial standards and supplied in 10 x 10 Alu-Alu Blister Pack with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-017 |
|---|---|
| Therapeutic Sector | Anti-Infectives & Antibiotics |
| Dosage Form | Supra-Bioavailable Pellet Capsules |
| Active Ingredient | Itraconazole BP / IP 100 mg (Pelletized) |
| Strength / Purity | 100 mg |
| Clinical Indication | Onychomycosis, systemic candidiasis, tinea corporis, histoplasmosis, and sporotrichosis |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 10 x 10 Alu-Alu Blister Pack |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C, protect from moisture & direct sunlight |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |